PolyPid Ltd. (PYPD) DCF Valuation

Valoración de DCF Polypid Ltd. (PYPD)

IL | Healthcare | Biotechnology | NASDAQ
PolyPid Ltd. (PYPD) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

PolyPid Ltd. (PYPD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Explore las perspectivas financieras de Polypid Ltd. (PYPD) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones con respecto al crecimiento, los márgenes y los gastos para calcular el valor intrínseco de Polypid Ltd. (PYPD) y mejorar su estrategia de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -5.9 -35.9 -41.5 -36.4 -20.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .9 1.0 1.1 1.7 1.8 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -6.9 -36.9 -42.6 -38.1 -22.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 26.6 44.5 32.2 12.6 5.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 -.3 .0 -.2 .0
Account Receivables, % 100 100 100 100 100
Inventories .4 .6 -22.5 .2 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.6 1.0 4.1 1.1 .8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.9 -1.2 -3.0 -1.8 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -0.28996 -0.28996 -0.28996 -0.28996 -0.28996 -0.28996 -0.28996 -0.28996 -0.28996 -0.28996
EBITAT 4.7 -35.3 -41.0 -38.2 -22.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 6.0 -36.1 -16.8 -63.7 -20.9 -.8 .0 .0 .0 .0
WACC, % 2.73 13.08 13.12 13.54 13.54 11.2 11.2 11.2 11.2 11.2
PV UFCF
SUM PV UFCF -.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt 6
Equity Value -7
Diluted Shares Outstanding, MM 1
Equity Value Per Share -4.89

What You Will Get

  • Comprehensive PYPD Financials: Access to both historical and projected data for precise valuation.
  • Customizable Inputs: Adjust parameters like WACC, tax rates, revenue growth, and capital expenditures.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess PolyPid's future performance.
  • User-Friendly Interface: Designed for experts but easy for newcomers to navigate.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for PolyPid Ltd. (PYPD).
  • WACC Calculator: Pre-designed Weighted Average Cost of Capital sheet with adjustable inputs specific to PYPD.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit PolyPid's projections.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to PolyPid Ltd. (PYPD).
  • Visual Dashboard and Charts: Graphical representations summarize essential valuation metrics for straightforward analysis.

How It Works

  • 1. Access the Model: Download and open the Excel file containing PolyPid Ltd.'s (PYPD) financial data.
  • 2. Adjust Variables: Modify essential inputs such as revenue growth, discount rates, and operating expenses.
  • 3. Analyze Results Immediately: The DCF model automatically computes the intrinsic value and net present value (NPV).
  • 4. Explore Scenarios: Evaluate various projections to understand different valuation possibilities.
  • 5. Present with Assurance: Deliver expert valuation insights to enhance your strategic decisions.

Why Choose This Calculator for PolyPid Ltd. (PYPD)?

  • Designed for Experts: A sophisticated tool utilized by industry analysts, financial officers, and strategic consultants.
  • Accurate Financial Insights: PolyPid’s historical and projected financial data preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly model various forecasts and assumptions to explore outcomes.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly Interface: Step-by-step guidance ensures a smooth calculation experience.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for assessing PolyPid Ltd. (PYPD) investment opportunities.
  • Biotech Corporate Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Offer clients precise valuation analyses for PolyPid Ltd. (PYPD) stock.
  • Students and Educators: Utilize real-time data to learn and teach financial modeling in the biotech sector.
  • Pharmaceutical Enthusiasts: Gain insights into how biotech firms like PolyPid Ltd. (PYPD) are valued in the market.

What the Template Contains

  • Pre-Filled Data: Contains PolyPid Ltd.'s historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model featuring automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC with user-defined inputs.
  • Key Financial Ratios: Assess PolyPid Ltd.'s profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visuals and tables that summarize essential valuation outcomes.

No products were found matching.